Abstract
Aims: Early tumor detection and intervention are important determinants of survival in patients with cancer. During early tumor growth, platelets actively and selectively sequester proteins and, as such, the platelet protein content can be used as a marker of early tumor growth. We therefore aimed at identifying differenzially expressed proteins of platelets that distinguish healthy controls from patients with early- and late-stage colorectal cancer. Such markers might serve for innovative early detection, prognosis and therapeutic intervention.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
